These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 1097102

  • 1. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
    Ahmann DL, Hahn RG, Bisel HF, Eagan RT, Edmonson JH.
    Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ, Falkson G.
    Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
    [Abstract] [Full Text] [Related]

  • 4. Treatment of small cell carcinoma of the lung using methyl-CCNU (NSC-95441) combined with cyclophosphamide (NSC-26271) and vincristine (NSC-67574) in a 3-week schedule.
    Taylor SG, Donavan MA, Sponzo RW, Cunningham TJ, Horton J.
    Cancer Chemother Rep; 1975; 59(6):1127-30. PubMed ID: 769951
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
    Ahmann DL, Hahn RG, Bisel HF.
    Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
    [No Abstract] [Full Text] [Related]

  • 6. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer.
    Rossi A, Riva A, Bonadonna G.
    Cancer Chemother Rep; 1975 Mar; 59(6):1161-2. PubMed ID: 769958
    [No Abstract] [Full Text] [Related]

  • 7. Clinical comparison of adriamycin and a combination of methyl-CCNU and imidazole carboxamide in disseminated malignant melanoma.
    Ahmann DL, Bisel HF, Edmonson JH, Hahn RG, Eagan RT, O'Connell MJ, Frytak S.
    Clin Pharmacol Ther; 1976 Jun; 19(6):821-4. PubMed ID: 773589
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK, Baker LH, Fraile RJ, Izbicki RM, Vaitkevicius VK.
    Cancer Treat Rep; 1977 Jun; 61(1):59-64. PubMed ID: 67895
    [Abstract] [Full Text] [Related]

  • 11. DTIC (NSC-45388) in malignant melanoma: a perspective.
    Comis RL.
    Cancer Treat Rep; 1976 Feb; 60(2):165-76. PubMed ID: 769969
    [No Abstract] [Full Text] [Related]

  • 12. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
    Livingston RB, Einhorn LH, Bodey GP, Burgess MA, Freireich EJ, Gottlieb JA.
    Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
    [Abstract] [Full Text] [Related]

  • 13. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Carter RD, Krementz ET, Hill GJ, Metter GE, Fletcher WS, Golomb FM, Grage TB, Minton JP, Sparks FC.
    Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
    [Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma.
    McKelvey EM, Luce JK, Talley RW, Hersh EM, Hewlett JS, Moon TE.
    Cancer; 1977 Jan; 39(1):1-4. PubMed ID: 832224
    [Abstract] [Full Text] [Related]

  • 15. Treatment of metastatic malignant melanoma with a combination of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).
    Gardere S, Hussain S, Cowan DH.
    Cancer Chemother Rep; 1972 Jun; 56(3):357-61. PubMed ID: 19051495
    [Abstract] [Full Text] [Related]

  • 16. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].
    Beretta G, Bajetta E, Bonadonna G, Tancini G, Orefice S, Veronesi U.
    Tumori; 1973 Jun; 59(3):239-48. PubMed ID: 4729646
    [No Abstract] [Full Text] [Related]

  • 17. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.
    Bellett RE, Mastrangelo MJ, Laucius JF, Bodurtha AJ.
    Cancer Treat Rep; 1976 May; 60(5):595-600. PubMed ID: 791478
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and imidazole carboxamide (NSC 45388) with vincristine (NSC 67574) in the palliation of disseminated malignant melanoma.
    Ahmann DL, Hahn RG, Bisel HF.
    Cancer Res; 1972 Nov; 32(11):2432-4. PubMed ID: 5082592
    [No Abstract] [Full Text] [Related]

  • 19. Use of methyl-CCNU and procarbazine in advanced malignant melanoma resistant to DTIC therapy.
    Didolkar MS, Baffi RR, Catane R, Kaufman J, Holyoke ED.
    Cancer Treat Rep; 1977 Dec; 61(9):1738-9. PubMed ID: 597824
    [No Abstract] [Full Text] [Related]

  • 20. Use of combination chemotherapy with CCNU, bleomycin, and vincristine in the treatment of metastatic melanoma in patients resistant to DTIC therapy.
    Everall JD, Dowd PM.
    Cancer Treat Rep; 1979 Jan; 63(1):151-5. PubMed ID: 84710
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.